Moreover, it has been described that detoxification enzymes such as GPx-6 significantly increased in the early stage of neurodegenerative diseases such as Parkinson’s and Huntington’s diseases as a compensatory mechanism for the increment of various toxic factors after the onset of the disease [50,51]. This evidence concerns the gene GPX6 and juvenile Huntington disease.